Allegheny Health Network Cardiovascular Institute First in Pittsburgh to Implant Groundbreaking Neuromodulation Device as Alternative Therapy for Heart Failure Patients

Barostim Baroreflex Activation Therapy is the world’s first FDA-approved device which uses the power of the brain and nervous system to improve symptoms of progressive heart failure

Related Keywords

Allegheny County ,Pennsylvania ,United States ,Americans ,American ,Srinivas Murali ,Satish Muluk ,Nadim Yared ,American Heart Association ,Journal Of The American College Cardiology ,Department Of Cardiovascular Medicine ,Allegheny Health Network ,Cardiovascular Institute ,Division Of Vascular Surgery ,Pa Department Of Health ,Allegheny General Hospital ,Barostim Baroreflex Activation Therapy ,Vascular Surgery ,System Chairman ,Greater Pittsburgh ,American College ,